LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $1.17 billion. The enterprise value is $988.89 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LENZ has 28.52 million shares outstanding. The number of shares has increased by 222.30% in one year.
| Current Share Class | 28.52M |
| Shares Outstanding | 28.52M |
| Shares Change (YoY) | +222.30% |
| Shares Change (QoQ) | +2.01% |
| Owned by Insiders (%) | 2.73% |
| Owned by Institutions (%) | 56.19% |
| Float | 13.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 231.74 |
| Forward PS | 47.58 |
| PB Ratio | 5.80 |
| P/TBV Ratio | 5.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 197.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.54, with a Debt / Equity ratio of 0.01.
| Current Ratio | 20.54 |
| Quick Ratio | 20.27 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.25% and return on invested capital (ROIC) is -19.26%.
| Return on Equity (ROE) | -26.25% |
| Return on Assets (ROA) | -18.44% |
| Return on Invested Capital (ROIC) | -19.26% |
| Return on Capital Employed (ROCE) | -29.94% |
| Revenue Per Employee | $454,545 |
| Profits Per Employee | -$4.76M |
| Employee Count | 11 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LENZ has paid $501,000 in taxes.
| Income Tax | 501,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +69.82% |
| 50-Day Moving Average | 34.72 |
| 200-Day Moving Average | 29.22 |
| Relative Strength Index (RSI) | 66.44 |
| Average Volume (20 Days) | 706,320 |
Short Selling Information
The latest short interest is 4.82 million, so 16.90% of the outstanding shares have been sold short.
| Short Interest | 4.82M |
| Short Previous Month | 3.82M |
| Short % of Shares Out | 16.90% |
| Short % of Float | 35.48% |
| Short Ratio (days to cover) | 8.07 |
Income Statement
In the last 12 months, LENZ had revenue of $5.00 million and -$52.40 million in losses. Loss per share was -$1.90.
| Revenue | 5.00M |
| Gross Profit | 5.00M |
| Operating Income | -61.96M |
| Pretax Income | -117.37M |
| Net Income | -52.40M |
| EBITDA | -61.87M |
| EBIT | -61.96M |
| Loss Per Share | -$1.90 |
Full Income StatementBalance Sheet
The company has $209.52 million in cash and $1.05 million in debt, giving a net cash position of $208.47 million or $7.31 per share.
| Cash & Cash Equivalents | 209.52M |
| Total Debt | 1.05M |
| Net Cash | 208.47M |
| Net Cash Per Share | $7.31 |
| Equity (Book Value) | 206.37M |
| Book Value Per Share | 7.24 |
| Working Capital | 203.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.22 million and capital expenditures -$685,000, giving a free cash flow of -$47.90 million.
| Operating Cash Flow | -47.22M |
| Capital Expenditures | -685,000 |
| Free Cash Flow | -47.90M |
| FCF Per Share | -$1.68 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,239.16% |
| Pretax Margin | -1,037.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -222.30% |
| Shareholder Yield | -222.30% |
| Earnings Yield | -4.38% |
| FCF Yield | -4.00% |
Dividend DetailsAnalyst Forecast
The average price target for LENZ is $49.75, which is 21.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.75 |
| Price Target Difference | 21.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LENZ has an Altman Z-Score of 38.28 and a Piotroski F-Score of 1.
| Altman Z-Score | 38.28 |
| Piotroski F-Score | 1 |
